I Jackson Zhu, MD, MBA, is the Chief Executive Officer and Founder of MBM, where he leads an integrated team of business, medical and scientific experts in building the company’s commercialization platform capabilities. He has worked in the pharmaceutical industry for more than 20 years, and has rich experience in a wide spectrum of roles including corporate strategy, M&A, business development and operations. Previously, he was the Greater China General Manager of Catalent, the world’s largest R&D and advanced drug delivery technology solution provider. He was also a VP and Europe Regional Business Head of Boehringer Ingelheim, focused on operations and business strategy. He was elected as a Global Director of Precision Medicine as part of the World Economic Forum.
Ariel Wu is the Vice President of Business Operations and Co-Founder of MBM. She is responsible for managing MBM’s operational activities, including finance, administration, personnel, and legal affairs. She has more than 20 years pharmaceutical industry experience with tenures in companies such as Johnson & Johnson, Roche and GlaxoSmithKline, taking on varied roles including product management, sales & marketing and business development. She managed and launched several blockbuster products in oncology and antiviral fields and was awarded GSK Asia Pacific President Award for outstanding performance.
Pang Liping is the Vice President of Sales and Marketing Operations and is responsible for leading a rapidly growing sales and marketing unit within MBM. He has more than 20 years experience in pharmaceutical and diagnostics sales & marketing, working for companies such as CSPC Pharmaceutical Group, BGI Genomics and Ebien Biotech. His successes include launching and growing a new cancer screening service that became the top-selling product in China, and managing a pharmaceutical sales department with over ¥2B in annual sales.
David J Kerr 教授
Håvard E Danielson 教授
全球结直肠癌联盟（Colorectal Cancer Network）主席
欧洲分析细胞病理学会（ESACP）秘书长（European Society of Analytical Cellular Pathology）
ESACP前任主席 (European Society of Analytical Cellular Pathology)
国际细胞肿瘤协会（ISCO） 首任主席(International Society for Cellular Oncology)
在全球高影响力杂志发表超过150 篇论文 ，包括 Nature、Lancet等
肖瑞平 M.D., Ph.D.